After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Recently, Yahoo Finance discussed the stock, revealing that United Therapeutics Corporation to Present at the TD Cowen 44th Annual Health Care Conference.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of United Therapeutics Corp is $10.62B. A total of 0.77 million shares were traded on the day, compared to an average of 364.89K shares.
Insider Activity
Insider trades can also provide insight into a stock’s future direction. During the recent three months, UTHR has seen 1 BUY and 4 SELL insider trades, representing the acquisition of 6,000 and the disposition of 6,000 shares. Over the last 12 months, there were 82 BUYs and 315 SELLs from insiders. Insiders purchased 472,100 shares during that period but sold 463,957.
In the most recent transaction, PATUSKY CHRISTOPHER sold 1,680 shares of UTHR for 224.00 per share on Feb 23. After the transaction, the Director now owns 4 company shares. In a previous transaction on Feb 15, MAHON PAUL A sold 6,000 shares at 215.31 per share. UTHR shares that EVP & GENERAL COUNSEL owns now total 36,599.
Among the insiders who sold shares, MAHON PAUL A disposed of 6,000 shares on Feb 01 at a per-share price of $215.01. This resulted in the EVP & GENERAL COUNSEL holding 36,599 shares of UTHR after the transaction. In another insider transaction, MAHON PAUL A sold 6,000 shares at $218.72 per share on Jan 18. Company shares held by the EVP & GENERAL COUNSEL now total 36,599.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. According to analysts who have offered 12-month price targets for UTHR in the last 3 months, the mean price target is $292.31 with high estimates of $375.00 and low estimates of $183.00. In terms of 52-week highs and lows, UTHR has a high of $261.54 and a low of $204.44.
As of this writing, UTHR has an earnings estimate of $5.63 per share for the current quarter. EPS was calculated based on a consensus of 12 estimates, with a high estimate of $6.53 per share and a lower estimate of $4.75. The company reported an EPS of $5.38 in the last quarter, which was 6.70% higher than expectations of $5.04.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. UTHR’s latest balance sheet shows that the firm has $1.93B in Cash & Short Term Investments as of fiscal 2021. There were $800.00M in debt and $305.40M in liabilities at the time. Its Book Value Per Share was $127.23, while its Total Shareholder’s Equity was $3.96B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for UTHR is Buy with a score of 4.53.
